Literature DB >> 21866899

Comparative evaluation of two structurally related flavonoids, isoliquiritigenin and liquiritigenin, for their oral infection therapeutic potential.

Mark Feldman1, Juliana Santos, Daniel Grenier.   

Abstract

Isoliquiritigenin (1) and liquiritigenin (2) are structurally related flavonoids found in a variety of plants. The purpose of this study was to perform a comparative analysis of biological properties of these compounds in regard to their therapeutic potential for oral infections. Compound 1 demonstrated significant antibacterial activity against three major periodontopathogens, Porphyromonas gingivalis, Fusobacterium nucleatum, and Prevotella intermedia. In contrast, 2 exerted less pronounced effects on the above bacterial species. Neither compound was effective against cariogenic bacteria (Streptococcus mutans and Streptococcus sobrinus). Furthermore, 1 exhibited a stronger inhibitory activity than 2 toward P. gingivalis collagenase and human matrix metalloproteinase 9. Finally, the capacity of 1 to attenuate the inflammatory response of macrophages induced by Aggregatibacter actinomycetemcomitans lipopolysaccharide (LPS) was much higher when compared to 2. The activation of transcriptional factors nuclear factor-κB (NF-κB) p65 and activator protein-1 (AP-1) associated with the LPS-induced inflammatory response in macrophages was inhibited strongly by 1, but less affected by 2.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866899     DOI: 10.1021/np200174h

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  13 in total

1.  Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.

Authors:  Tareisha L Dunlap; Shuai Wang; Charlotte Simmler; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2015-07-16       Impact factor: 3.739

2.  Dynamic residual complexity of the isoliquiritigenin-liquiritigenin interconversion during bioassay.

Authors:  Charlotte Simmler; Atieh Hajirahimkhan; David C Lankin; Judy L Bolton; Tristesse Jones; Djaja D Soejarto; Shao-Nong Chen; Guido F Pauli
Journal:  J Agric Food Chem       Date:  2013-02-22       Impact factor: 5.279

3.  Evaluation of flavonoid and resveratrol chemical libraries reveals abyssinone II as a promising antibacterial lead.

Authors:  Dianqing Sun; Julian G Hurdle; Robin Lee; Richard Lee; Mark Cushman; John M Pezzuto
Journal:  ChemMedChem       Date:  2012-07-30       Impact factor: 3.466

4.  Systematic exploration of natural and synthetic flavonoids for the inhibition of Staphylococcus aureus biofilms.

Authors:  Suvi Manner; Malena Skogman; Darla Goeres; Pia Vuorela; Adyary Fallarero
Journal:  Int J Mol Sci       Date:  2013-09-25       Impact factor: 5.923

5.  Isoliquiritigenin decreases the incidence of colitis-associated colorectal cancer by modulating the intestinal microbiota.

Authors:  Minna Wu; Yaqi Wu; Baoguo Deng; Jinsong Li; Haiying Cao; Yan Qu; Xinlai Qian; Genshen Zhong
Journal:  Oncotarget       Date:  2016-12-20

Review 6.  Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models.

Authors:  Mahesh Ramalingam; Hyojung Kim; Yunjong Lee; Yun-Il Lee
Journal:  Front Aging Neurosci       Date:  2018-11-01       Impact factor: 5.750

7.  Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation.

Authors:  Po-Han Lin; Hsiang-Lin Kung; Hsin-Yuan Chen; Ko-Chieh Huang; Shih-Min Hsia
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

Review 8.  The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids.

Authors:  Michał Ciebiera; Mohamed Ali; Lillian Prince; Tia Jackson-Bey; Ihor Atabiekov; Stanisław Zgliczyński; Ayman Al-Hendy
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

9.  Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent.

Authors:  Fengchang Huang; Jin Wang; Yi Xu; Yunfei Zhang; Ning Xu; Liang Yin
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

10.  Isoliquiritigenin attenuates spinal tuberculosis through inhibiting immune response in a New Zealand white rabbit model.

Authors:  Wenjing Wang; Baozhi Yang; Yong Cui; Ying Zhan
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.